In the third quarter, Financial Consulate Inc. initiated a new position of 8,220 shares in Procter & Gamble, representing an investment of approximately 1.26 million dollars. During the subsequent quarter, Brighton Jones LLC increased its holdings by 51.5%, adding 13,617 shares to bring its total to 40,068 shares valued at roughly 6.72 million dollars. Taylor Financial Group Inc. lifted its stake by 10.6% in the first quarter, acquiring an additional 277 shares to reach 2,891 shares worth about 493,000 dollars. Smaller entrants included Quarry LP, which purchased a stake valued at 33,000 dollars, Bosun Asset Management LLC, which grew its position by 8.9% to 2,723 shares valued at 464,000 dollars, and Copperleaf Capital LLC, which placed 213,000 dollars into new shares. Collectively, institutional investors now control 65.77% of the company’s outstanding shares.

Matthew W. Janzaruk, the company’s Chief Accounting Officer, sold 725 shares on October 30 in a single transaction averaging 149.57 dollars per share, generating proceeds of approximately 108,438 dollars. Following this sale, his personal holdings declined by 42.6% to 979 shares, now valued at around 146,430 dollars. This marks a notable shift in insider sentiment, reducing executive ownership to just 0.20% of total shares outstanding.

Over the past four months, thirteen research firms have maintained a constructive stance, assigning a Buy rating, while ten have issued Hold recommendations—culminating in a consensus of Moderate Buy. UBS trimmed its target from 180.00 to 176.00 in early October yet upheld a Buy rating. Barclays and JPMorgan Chase & Co. each lowered their objectives to 151.00 and 157.00 respectively, with Barclays moving to Equal Weight and JPMorgan affirming Neutral. Berenberg Bank bucked the trend by raising its price projection from 152.00 to 154.00 and sustaining a Hold recommendation. The average analyst target stands at 171.38, underscoring continued confidence in the company’s mid-term growth prospects.